First humans test new Two-Target asthma & COPD drug
NCT ID NCT07262281
Summary
This is a first-in-human study to check the safety and see how the body processes a new drug called HY6725. It will involve 74 healthy adults who will receive either the drug or a placebo (an inactive substance) through injections under the skin. The main goal is to see if the drug is safe and well-tolerated, and to measure how long it stays in the body, with follow-up lasting about 5 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network Pty Ltd.
RECRUITINGMelbourne, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.